There are currently 12 GLP-1 agonists approved for use by the U.S. Food and Drug Administration (FDA): Victoza, first approved by the FDA in 2010, has the same indications for use as Ozempic ...

Hikma recently received the Food and Drug Administration’s permission ... The FDA approved Hikma's first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon ...